VistaGen Therapeutics, Inc.
-
Ticker
VTGN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1-10 Employees
- Based in South San Francisco, California
VistaGen Therapeutics is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen's three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential
…More in multiple CNS markets.
REPORT RATINGS
4.8 / 5.0 (154)
VistaGen Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 154 reviews.
VistaGen Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports